Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
| Company Name | Founded | Funding Stage | Amount | City |
|---|---|---|---|---|
| Coral Genomics | 2021 | Grant | $1.7M | San Francisco |
| Photonic Pharma | 2021 | Grant | $499K | Minneapolis |
| Novosteo | 2021 | Series A | $5.5M | Indiana |
| Celldom, Inc | 2021 | Seed | Undisclosed | Durham |
| Intake Health | 2020 | Grant | $1.0M | Raleigh |
| Gooddler | 2020 | Seed | $55K | San Francisco |
| Enrich Therapeutics | 2020 | Grant | $1.7M | Worcester |
| Scioto Biosciences | 2020 | Series B | $26.5M | Indianapolis |
| OneClick.chat | 2020 | Grant | $1.8M | Philadelphia |
| Haima Therapeutics | 2020 | Grant | $949K | Cleveland |
| # | Company | Stage | Amount | Location |
|---|---|---|---|---|
| 251 | Coral Genomics | Grant | $1.7M | San Francisco, United States |
| 252 | Photonic Pharma | Grant | $499K | Minneapolis, United States |
| 253 | Novosteo | Series A | $5.5M | Indiana, United States |
| 254 | Celldom, Inc | Seed | Undisclosed | Durham, United States |
| 255 | Intake Health | Grant | $1.0M | Raleigh, United States |
| 256 | Gooddler | Seed | $55K | San Francisco, United States |
| 257 | Enrich Therapeutics | Grant | $1.7M | Worcester, United States |
| 258 | Scioto Biosciences | Series B | $26.5M | Indianapolis, United States |
| 259 | OneClick.chat | Grant | $1.8M | Philadelphia, United States |
| 260 | Haima Therapeutics | Grant | $949K | Cleveland, United States |
Coral develops new clinical tests to help providers streamline prior authorization and select the effective medication.
Photonic Pharma is an early phase of drug development
Novosteo, test the efficacy of a new drug to help reduce complications from a broken bone due to a fall.
Find and study cells that make diseases incurable
A continuous, passive, home-health remote monitoring platform.
GOODdler - connecting local needs with local resources
Enrich Therapeutics is a biotechnology startup.
Scioto is a developer of Activated Bacterial Therapeutics platform.
OneClick.chat is an innovative video chat platform.
Haima Therapeutics is a pre-clinical stage biotechnology company.
HeartVista is a medical technology company.
CinderBio produces the world's most stable enzymes from amazing microbes that thrive in hot acidic volcanic waters around the globe.
Cicero Diagnostics is a women’s healthcare diagnostic company.
Theraly is a preclinical-stage company whose mission is to develop innovative treatments for various forms of fibrotic disease.
FIRMM is a real-time MRI quality metrics to reduce costs and improve quality. Jointly developed by the Fair (OHSU) & Dosenbach (WashU) labs.
Improving the world for animals, plants and people by commercializing sensors for fine and ultra fine airborne particulate matter detection.
Infondrian provides data-driven insights for cancer care.
SciBac is a developer of biotherapeutics intended to treat antibiotic diseases.
UroDev Medical is develops a fully-internal, smart catheter for bladder management.
Embolx is a medical device start-up that manufactures and sells novel embolization microcatheters to treat cancer.
SYMIC Biomedical operates in the healthcare industry focusing on biotechnology business.
Precision Virologics is a St. Louis-based biotech startup.
CerSci Therapeutics is poised to deliver a new generation of non-opioid medicines to treat acute and chronic pain.
DILIsym Services provides drug-induced liver injury simulation software and related consulting services.
Wicked Device is a Works member company.
National Institutes of Health has invested in 288 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
National Institutes of Health's top investment sectors include Health Care, Biotechnology, Pharmaceutical, Health Diagnostics, Therapeutics. The firm invests across 48 different industry categories.
Among tracked funding rounds, Scioto Biosciences received $26.5M in a Series B round. National Institutes of Health's total known invested capital is $1.3B.
National Institutes of Health's average investment size is $6.6M across its portfolio of 288 companies.
Recent National Institutes of Health portfolio additions include Coral Genomics, Photonic Pharma, Novosteo, Celldom, Inc, Intake Health. These companies were founded in 2020 or later.
Discover portfolio companies of other leading venture capital firms and investors.
View All Investors